Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy

American Journal of Gastroenterology

Volumn 104, Issue 7, 2009, Pages 1764-1771

  Beaumont, Hanneke ^a   Boeckxstaens, Guy E E ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; BACLOFEN; PLACEBO; PROTON PUMP INHIBITOR;

ADD ON THERAPY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL REFLUX; HIATUS HERNIA; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; BACLOFEN; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GABA AGONISTS; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HERNIA, HIATAL; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; PROBABILITY; PROTON PUMP INHIBITORS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67650461959     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.247     Document Type: Article

References (49)

1. Heading RC. Prevalence of upper gastrointestinal symptoms in the general population: a systematic review . Scand J Gastroenterol Suppl 1999 ; 231 : 3-8.
2. Locke GR III, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County Minnesota . Gastroenterology 1997 ; 112 : 1448-56.
3. Valle C, Broglia F, Pistorio A et al. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease . Dig Dis Sci 1999 ; 44 : 1848-52.
4. Chiba N De Gara CJ, Wilkinson JM et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis . Gastroenterology 1997 ; 112 : 1798-810.
5. Fass R, Shapiro M, Dekel R et al. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next? Aliment Pharmacol Ther 2005;22:79-94.
6. Hetzel DJ, Dent J, Reed WD et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole . Gastroenterology 988;95:903- 12.
7. Holloway RH, Dent J, Narielvala F et al. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut 1996;38:649-54.
8. Klinkenberg-Knol EC, Nelis F, Dent J et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa . Gastroenterology 2000 ; 118 : 661-9.
9. Vela MF, Camacho-Lobato L, Srinivasan R et al. Simultaneous intraesopha-geal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole . Gastroenterology 2001 ; 120 : 1599-606.
10. Hatlebakk JG, Katz PO, Castell DO. Medical therapy. Management of the refractory patient. Gastroenterol Clin North Am 999;28:847-60.
11. Tack J, Koek G, Demedts I et al. Gastroesophageal refux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both? Am J Gastroenterol 2004;99:981-8.
12. Dent J, Dodds WJ, Friedman RH et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects . J Clin Invest 980;65:256-67.
13. Dodds WJ, Dent J, Hogan WJ et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis . N Engl J Med 1982 ; 307 : 1547-52.
14. Holloway RH. The anti-reflux barrier and mechanisms of gastro-oesopha-geal reflux . Baillieres Best Pract Res Clin Gastroenterol 2000 ; 14 : 681-99.
15. Sifrim D, Holloway R, Silny J et al. Composition of the postprandial refux-ate in patients with gastroesophageal reflux disease . Am J Gastroenterol 2001;96:647-55.
16. Kahrilas PJ. The role of hiatus hernia in GERD . Yale J Biol Med 1999;72:10-1.
17. Barham CP, GotleyDC, Mills A et al. Precipitating causes of acid reflux episodes in ambulant patients with gastro-oesophageal reflux disease. Gut 1995;36:505-10.
18. van Herwaarden MA, Samsom M, Smout AJ. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations . Gastroenterology 2000 ; 119 : 1439-46.
19. Mittal RK, Lange RC, McCallum RW. Identifcation and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia . Gastroenterology 1987;92:30-5.
20. Pandolfno JE, Shi G, Trueworthy B et al. Esophagogastric junction opening during relaxation distinguishes nonhernia reflux patients, hernia patients, and normal subjects . Gastroenterology 2003 ; 125 : 1018-24.
21. Sloan S, Kahrilas PJ. Impairment of esophageal emptying with hiatal hernia . Gastroenterology 1991;100:596-605.
22. Kahrilas PJ, Lin S, Chen J et al. The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut 1999;44:476-82.
23. Berstad A, Weberg R, Froyshov LI et al. Relationship of hiatus hernia to reflux oesophagitis. A prospective study of coincidence, using endoscopy Scand J Gastroenterol 1986 ; 21 : 55-8.
24. Kasapidis P, Vassilakis JS Tzovaras G et al. Efect of hiatal hernia on esophageal manometry and pH-metry in gastroesophageal reflux disease . Dig Dis Sci 1995 ; 40 : 2724-30.
25. Ott DJ, Glauser SJ, Ledbetter MS et al. Association of hiatal hernia and gastroesophageal reflux: correlation between presence and size of hiatal hernia and 24-hour pH monitoring of the esophagus . AJR Am J Roentgenol 1995;165:557-9.
26. Wright RA, Hurwitz AL. Relationship of hiatal hernia to endoscopically proved reflux esophagitis . Dig Dis Sci 1979 ; 24 : 311-3.
27. Kahrilas PJ, Shi G, Manka M et al. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia . Gastroenterology 2000 ; 118 : 688-95.
28. Lidums I, Lehmann A, Checklin H et al. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 2000;118:7-13.
29. Lee KJ, Vos R, Janssens J et al. Diferential effects of baclofen on lower oesophageal sphincter pressure and proximal gastric motility in humans . Aliment Pharmacol Ther 2003;18:99-207.
30. Koek GH, Sifrim D, Lerut T et al. Efect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors . Gut 2003 ; 52 : 1397-402.
31. Vela MF, Tutuian R, Katz PO et al. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH . Aliment Pharmacol Ther 2003;17:243-5.
32. Zhang Q, Lehmann A, Rigda R et al. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002;50:19-24.
33. Cange L, Johnsson E, Rydholm H et al. Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease. Aliment Pharmacol Ther 2002;16:869-73.
34. van Herwaarden MA, Samsom M, Rydholm H et al. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease . Aliment Pharmacol Ther 2002 ; 16 : 1655-62.
35. Ciccaglione AF, Marzio L. Efect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 2003;52:464-70.
36. Grossi L, Spezzaferro M Sacco LF et al. Efect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study . Neurogastroenterol Motil 2008;20:760-6.
37. Sifrim D, Holloway R, Silny J et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-im-pedance recordings . Gastroenterology 2001 ; 120 : 1588-98.
38. Zerbib F, des Varannes SB, Roman S et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects . Aliment Pharmacol Ther 2005 ; 22 : 1011-21.
39. Zerbib F, Roman S, Ropert A et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy . Am J Gastroenterol 2006 ; 101 : 1956-63.
40. Mainie I, Tutuian R, Shay S et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy. A multicentre study using combined ambulatory impedance-pH monitoring . Gut 2006 ; 55 : 1398-402.
41. Tutuian R, Vela MF, Hill EG et al. Characteristics of symptomatic reflux episodes on acid suppressive therapy . Am J Gastroenterol 2008 ; 103 : 1090-6.
42. Bredenoord AJ, Weusten BL, Timmer R et al. Air swallowing, belching, and reflux in patients with gastroesophageal reflux disease . Am J Gastroenterol 2006 ; 101 : 1721-6.
43. Wyman JB, Dent J, Heddle R et al. Control of belching by the lower oesophageal sphincter. Gut 990;31:639-46.
44. Tuttle SG, Rufin F, Bettarello A. The physiology of heartburn . Ann Intern Med 961;55:292-300.
45. Emerenziani S, Habib FI, Rib olsi M et al. Efect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients . Aliment Pharmacol Ther 2006;23:751-7.
46. Kahrilas PJ, Dodds WJ, Hogan WJ. Efect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 1988;94:73-80.
47. Emerenziani S, Zhang X, Blondeau K et al. Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux . Am J Gastroenterol 2005 ; 100 : 1251-6.
48. Zerbib F, Duriez A, Roman S et al. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 2008;57:156-60.
49. Bredenoord AJ, Weusten BL, Curvers WL et al. Determinants of perception of heartburn and regurgitation. Gut 2006;55:313-8. 50 . Cicala M, E merenziani S, Caviglia R et al. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease . Aliment Pharmacol Ther 2003;18:605-13.